The CDTI invests, together with Nuubo Investments in Smart Solutions Technologies (Nuubo), medical devices company for the monitoring and analysis of the
The CDTI Innovation, through its programme, together with Innvierte Nuubo Investments FCRE, has reached an agreement with the partners of SMART SOLUTIONS TECHNOLOGIES, S.L. (NUUBO), to make a further contribution in the capital of the company
Nuuboit is a spanish medtech who has developed a pioneering system of biosensores 3D print on conventional textiles capable of detecting and diagnose irregular heart rates.
With a consolidated position in spain after the release of Nuubo System in 2018, tool that has monitored the electrocardiogram (ECG) of more than 160,000 patients, Nuubo has managed to build a strong market share home monitoring in spain. In practice, works in 75% of all Stroke in Spain, also found in the 60% of all cardiology, starting a new expansion phase after closing a round of investment that has got something more than eur 9 million in the past two years.
This amount will be used to settle in other regions, especially in america, where nearly 65 per cent of the global market cardiac monitoring.
The diagnosis of Nuubo system to monitor better the arrhythmias in patients, reducing the possibility of diseases linked to atrial fibrillation (FA). The to follow more widespread in the time, Nuubo enables continuous registers for 30 days compared to 24-48 hours of the technologies as well as the Holter, which means that it has managed to increase in ten times the profitability of the diagnostic FA thanks to Nuubo.
NUUBO INVESTMENTS
Nuubo Investments, European Venture Capital (FCRE), registered in the national securities market (CNMV) and managed by Health Tech SGEIC BRC, SA (before Inverbio BRC), is a fund dedicated to invest exclusively in Nuubo y sus afiliadas. With a target size of up to €5M and authorised by the programme Innvierte of CDTI, Nuubo Investments FCRE has led the round of investment in Nuubo that will enable This launching in the us market. BRC Health Tech SGEIC, SA, is a specialized private investment in investment funds in start ups technological base in the area of life sciences. Health Tech SGEIC BRC, SA manages BRC also Bio II RCF, partner and investor Nuubo reference from 2013.
CDTI Innovation
The CDTI innovation is the public funding of innovation of the ministry of science, innovation and universities that promotes innovation and technological development of spanish companies, channeling requests for funding and support for r & D & I projects of spanish entities at the state and international levels. We Contribute to the improvement of the technological level of spanish companies and drive and, with an international network with coverage of 51 countries support the spanish participation in international programmes for technology cooperation and the international transfer of technology.
Additionally, through the initiative Innvierte Sustainable Economy, supports and facilitates the capitalization of technology companies. To date, the CDTI, through Innvierte, has committed over 384 M €in 20 investment vehicles that have invested in more than 250 businesses, and through its joint investment line directly committed an amount of more than 431 M €in at least 144 companies.
The centre for technological development and innovation, E.P.E. (CDTI) is a public entity under the ministry of Science, innovation and universities.
More information:
Office of the press
prensa@cdti.es
91-581.55.00
On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
X:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial
This content is copyright © 2024 CDTI, Soes. Permitted for use and reproduction by quoting the source and digital identity of CDTI (@CDTI _ innovation).